Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

BXL-628 has relevant molecular effects in experimental autoimmune prostatitis

Dec. 7, 2006

Pfizer's novel EP1 receptor antagonist may be useful to treat incontinence

Dec. 4, 2006

Novel agents for treating renal and urological disorders disclosed in recent patents

Dec. 1, 2006

Cetrorelix set to begin phase III for BPH

Dec. 1, 2006

Targets in nephrology

Nov. 29, 2006

Snapshots on novel targets in autosomal dominant polycystic kidney disease

Nov. 28, 2006

Xanthine oxidase inhibition by natural decursinol shows benefit in a rat model of hyperuricemia

Nov. 27, 2006

Novel melanocortin agonist shows efficacy in animal models of acute renal failure

Nov. 24, 2006

Snapshots: New data from clinical studies of drug candidates for renal diseases

Nov. 23, 2006

Anti-ICOSL mAb shows promising results in experimental autoimmune glomerulonephritis

Nov. 23, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...